Pharmena Statistics

Total Valuation

Pharmena has a market cap or net worth of PLN 39.65 million. The enterprise value is 38.15 million.

Market Cap	39.65M
Enterprise Value	38.15M

Important Dates

The last earnings date was Friday, May 23, 2025.

Earnings Date	May 23, 2025
Ex-Dividend Date	n/a

Share Statistics

Pharmena has 11.14 million shares outstanding.

Current Share Class	11.14M
Shares Outstanding	11.14M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	10.51%
Owned by Institutions (%)	3.07%
Float	3.12M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	147.95
PB Ratio	3.19
P/TBV Ratio	3.51
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-30.23
EV / Sales	142.35
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-14.07

Financial Position

The company has a current ratio of 12.98, with a Debt / Equity ratio of 0.02.

Current Ratio	12.98
Quick Ratio	2.22
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-0.09
Interest Coverage	-89.55

Financial Efficiency

Return on equity (ROE) is -7.29% and return on invested capital (ROIC) is -12.13%.

Return on Equity (ROE)	-7.29%
Return on Assets (ROA)	-11.30%
Return on Invested Capital (ROIC)	-12.13%
Return on Capital Employed (ROCE)	-26.98%
Revenue Per Employee	38,286
Profits Per Employee	-180,286
Employee Count	7
Asset Turnover	0.01
Inventory Turnover	0.12

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -42.39% in the last 52 weeks. The beta is 0.61, so Pharmena's price volatility has been lower than the market average.

Beta (5Y)	0.61
52-Week Price Change	-42.39%
50-Day Moving Average	4.12
200-Day Moving Average	4.73
Relative Strength Index (RSI)	38.33
Average Volume (20 Days)	13,966

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Pharmena had revenue of PLN 268,000 and -1.26 million in losses. Loss per share was -0.11.

Revenue	268,000
Gross Profit	198,000
Operating Income	-3.40M
Pretax Income	-2.56M
Net Income	-1.26M
EBITDA	-3.38M
EBIT	-3.40M
Loss Per Share	-0.11

Full Income Statement

Balance Sheet

The company has 1.75 million in cash and 244,000 in debt, giving a net cash position of 1.50 million or 0.13 per share.

Cash & Cash Equivalents	1.75M
Total Debt	244,000
Net Cash	1.50M
Net Cash Per Share	0.13
Equity (Book Value)	12.42M
Book Value Per Share	1.12
Working Capital	10.96M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -2.53 million and capital expenditures -180,000, giving a free cash flow of -2.71 million.

Operating Cash Flow	-2.53M
Capital Expenditures	-180,000
Free Cash Flow	-2.71M
FCF Per Share	-0.24

Full Cash Flow Statement

Margins

Gross Margin	73.88%
Operating Margin	-1,269.78%
Pretax Margin	-954.10%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.85, which amounts to a dividend yield of 24.29%.

Dividend Per Share	0.85
Dividend Yield	24.29%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	2
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	24.29%
Earnings Yield	-3.18%
FCF Yield	-6.84%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pharmena has an Altman Z-Score of 37.89.

Altman Z-Score	37.89
Piotroski F-Score	n/a